Science1 month ago
Xenon Pharmaceuticals’ Seizure Drug Achieves Key Trial Milestone
Xenon Pharmaceuticals has announced promising results from a Phase 3 clinical trial for its seizure treatment, azetukalner. The trial demonstrated a significant reduction in seizure frequency...